Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux.
暂无分享,去创建一个
Heng Zhang | Chad A Mirkin | C Shad Thaxton | C. Mirkin | C. Thaxton | D. Giljohann | Dongwoo Kim | David A Giljohann | Andrea J Luthi | Dongwoo Kim | Andrea J. Luthi | Heng Zhang
[1] J. Storhoff,et al. A DNA-based method for rationally assembling nanoparticles into macroscopic materials , 1996, Nature.
[2] G. Zampighi,et al. Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. , 1981, Biochemistry.
[3] Chad A Mirkin,et al. Silver nanoparticle-oligonucleotide conjugates based on DNA with triple cyclic disulfide moieties. , 2007, Nano letters.
[4] T. Hazlett,et al. Optical spectroscopy in studies of antibody-hapten interactions. , 2000, Methods.
[5] S. Nissen,et al. ETC-216 for coronary artery disease , 2011, Expert opinion on biological therapy.
[6] A. Jonas. Reconstitution of high-density lipoproteins. , 1986, Methods in enzymology.
[7] A. Jonas,et al. CHAPTER 17 – Lipoprotein structure , 2008 .
[8] Christopher K. Glass,et al. Atherosclerosis The Road Ahead , 2001, Cell.
[9] Axel Thran,et al. Atherosclerotic Plaque Composition : Analysis with Multicolor CT and Targeted Gold Nanoparticles 1 , 2010 .
[10] A. Chattopadhyay. Chemistry and biology of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-labeled lipids: fluorescent probes of biological and model membranes. , 1990, Chemistry and physics of lipids.
[11] C. Mirkin,et al. Bioluminescent nanosensors for protease detection based upon gold nanoparticle-luciferase conjugates. , 2010, Chemical communications.
[12] G. Anantharamaiah,et al. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. , 1992, Journal of lipid research.
[13] C. Mirkin,et al. Polyvalent nucleic acid nanostructures. , 2011, Journal of the American Chemical Society.
[14] L. Curtiss,et al. Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma , 2010, Nature Structural &Molecular Biology.
[15] Chad A. Mirkin,et al. Gold nanoparticles for biology and medicine. , 2010, Angewandte Chemie.
[16] U. Igbavboa,et al. Lipid binding to sterol carrier protein-2 is inhibited by ethanol. , 1999, Biochimica et biophysica acta.
[17] Erling Falk,et al. Pathogenesis of atherosclerosis. , 2006, Journal of the American College of Cardiology.
[18] A J Mendez,et al. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. , 1997, Journal of lipid research.
[19] Jianwen Fang,et al. Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes , 2008, Proceedings of the National Academy of Sciences.
[20] Zahi A Fayad,et al. The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis. , 2011, Biomaterials.
[21] J. Storhoff,et al. Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. , 1997, Science.
[22] C. Mirkin,et al. Templated spherical high density lipoprotein nanoparticles. , 2009, Journal of the American Chemical Society.
[23] Mathias Brust,et al. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system , 1994 .
[24] Aldons J. Lusis,et al. Atherosclerosis : Vascular biology , 2000 .
[25] Z. Fayad,et al. Quantum dot and Cy5.5 labeled nanoparticles to investigate lipoprotein biointeractions via Förster resonance energy transfer. , 2010, Nano letters.
[26] R. Lanford,et al. Signal-mediated nuclear transport in simian virus 40-transformed cells is regulated by large tumor antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] Serkalem Demissie,et al. Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[28] M Sutton,et al. Polymer-stabilized gold nanoparticles and their incorporation into polymer matrices. , 2001, Journal of the American Chemical Society.
[29] Paul Schoenhagen,et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.
[30] Elina Ikonen,et al. Cellular cholesterol trafficking and compartmentalization , 2008, Nature Reviews Molecular Cell Biology.
[31] D. Vance,et al. Biochemistry of Lipids, Lipoproteins and Membranes , 2002 .
[32] D. Rader,et al. Laboratory assessment of HDL heterogeneity and function. , 2008, Clinical chemistry.
[33] P. Williams,et al. Polyacrylamide gradient gel electrophoresis of lipoprotein subclasses. , 2006, Clinics in laboratory medicine.
[34] Chad A. Mirkin,et al. Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation , 2006, Science.
[35] Claudia Calcagno,et al. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. , 2008, Nano letters.
[36] M. K. Brennaman,et al. Critical flocculation concentrations, binding isotherms, and ligand exchange properties of peptide-modified gold nanoparticles studied by UV-visible, fluorescence, and time-correlated single photon counting spectroscopies. , 2003, Analytical chemistry.
[37] E. Schaefer,et al. Metabolic and functional relevance of HDL subspecies , 2011, Current opinion in lipidology.
[38] D. Astruc,et al. Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum‐Size‐Related Properties, and Applications Toward Biology, Catalysis, and Nanotechnology. , 2004 .
[39] E. Favari,et al. Relative Contributions of ABCA1 and SR-BI to Cholesterol Efflux to Serum From Fibroblasts and Macrophages , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[40] M C Hjortland,et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.
[41] G. Franceschini,et al. Synthetic high density lipoproteins for the treatment of myocardial ischemia/reperfusion injury. , 2006, Pharmacology & therapeutics.
[42] T. B. Thompson,et al. The Structure of Apolipoprotein A-I in High Density Lipoproteins* , 2007, Journal of Biological Chemistry.
[43] Y. Marcel,et al. Apolipoprotein A-I: structure-function relationships. , 2000, Journal of lipid research.
[44] G. Francis,et al. Cholesterol and phospholipid efflux from cultured cells. , 2005, Methods.
[45] Minghan Wang,et al. HDL: The Metabolism, Function, and Therapeutic Importance , 2004 .
[46] R. Traut,et al. Addition of sulfhydryl groups to Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate). , 1978, Biochemistry.
[47] B. Staels,et al. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis. , 2009, Biochemical pharmacology.
[48] L. Margaritis,et al. Visualisation of liposomes prepared from skin and stratum corneum lipids by transmission electron microscopy. , 2007, Micron.
[49] C. Mirkin,et al. Peptide antisense nanoparticles , 2008, Proceedings of the National Academy of Sciences.
[50] Chad A Mirkin,et al. Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. , 2011, Nano letters.
[51] H. Jiang,et al. Synthesis of Gold Nanoparticles Grafted with a Thermoresponsive Polymer by Surface-Induced Reversible-Addition-Fragmentation Chain-Transfer Polymerization , 2003 .
[52] Xiaohua Huang,et al. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. , 2005, Nano letters.
[53] C. Mirkin,et al. Polyvalent oligonucleotide iron oxide nanoparticle "click" conjugates. , 2010, Nano letters.
[54] Peter Libby,et al. Lipoprotein Disorders and Cardiovascular Disease , 2012 .
[55] Inder Singh,et al. High-density lipoprotein as a therapeutic target: a systematic review. , 2007, JAMA.
[56] L. Cupples,et al. High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study , 2004, Arteriosclerosis, thrombosis, and vascular biology.